Literature DB >> 16272526

Broth microdilution susceptibility testing of Brucella species: quality control limits for ten antimicrobial agents against three standard quality control strains.

Steven D Brown1, Maria M Traczewski.   

Abstract

Brucella broth without supplementation is the recommended medium for broth microdilution susceptibility tests of Brucella abortus, B. melitensis, and B. suis. Based on an eight-laboratory collaborative study using a pH-adjusted modification of this medium, we propose MIC quality control ranges for three control strains against 10 antimicrobials that are potentially efficacious for treating infections caused by these agents of bioterrorism.

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16272526      PMCID： PMC1287786          DOI： 10.1128/JCM.43.11.5804-5807.2005

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  15 in total

1.  Recommendations for susceptibility tests on fastidious organisms and those requiring special handling.

Authors:  A King
Journal:  J Antimicrob Chemother       Date:  2001-07       Impact factor: 5.790

2.  In vitro activity of azithromycin and tetracycline against 358 clinical isolates of Brucella melitensis.

Authors:  R Landínez; J Liñares; E Loza; J Martínez-Beltrán; R Martín; F Baquero
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-03       Impact factor: 3.267

3.  Susceptibility of Brucella melitensis to fluoroquinolones.

Authors:  S M Qadri; M Akhtar; Y Ueno; M B al-Sibai
Journal:  Drugs Exp Clin Res       Date:  1989

Review 4.  Modern chemotherapy for brucellosis in humans.

Authors:  W H Hall
Journal:  Rev Infect Dis       Date:  1990 Nov-Dec

5.  In vitro activities of six new fluoroquinolones against Brucella melitensis.

Authors:  I Trujillano-Martín; E García-Sánchez; I M Martínez; M J Fresnadillo; J E García-Sánchez; J A García-Rodríguez
Journal:  Antimicrob Agents Chemother       Date:  1999-01       Impact factor: 5.191

6.  Statistical criteria for selecting quality control limits for broth microdilution susceptibility tests with 39 different antimicrobial agents. Collaborative Antimicrobial Susceptibility Testing Group.

Authors:  A L Barry; P C Fuchs; R N Jones
Journal:  Diagn Microbiol Infect Dis       Date:  1989 Sep-Oct       Impact factor: 2.803

7.  In vitro susceptibility of Brucella to various antibiotics.

Authors:  W H Hall; R E Manion
Journal:  Appl Microbiol       Date:  1970-10

Review 8.  The microbiology laboratory's role in response to bioterrorism.

Authors:  Barbara Robinson-Dunn
Journal:  Arch Pathol Lab Med       Date:  2002-03       Impact factor: 5.534

9.  Susceptibility of Mexican brucella isolates to moxifloxacin, ciprofloxacin and other antimicrobials used in the treatment of human brucellosis.

Authors:  Ahidé López-Merino; Araceli Contreras-Rodríguez; Roberto Migranas-Ortiz; Rubén Orrantia-Gradín; Gerardo M Hernández-Oliva; Arturo Torres Y Gutiérrez-Rubio; Oscar Cardeñosa
Journal:  Scand J Infect Dis       Date:  2004

10.  Open, randomized therapeutic trial of six antimicrobial regimens in the treatment of human brucellosis.

Authors:  J M Montejo; I Alberola; P Glez-Zarate; A Alvarez; J Alonso; A Canovas; C Aguirre
Journal:  Clin Infect Dis       Date:  1993-05       Impact factor: 9.079
View more
  3 in total

1.  Statistical methods for establishing quality control ranges for antibacterial agents in Clinical and Laboratory Standards Institute susceptibility testing.

Authors:  John Turnidge; Gerry Bordash
Journal:  Antimicrob Agents Chemother       Date:  2007-04-16       Impact factor: 5.191

2.  Effect of carbon dioxide on broth microdilution susceptibility testing of Brucella spp.

Authors:  David R Lonsway; Laura A Jevitt; James R Uhl; Franklin R Cockerill; Mary E Anderson; Maureen M Sullivan; Barun K De; Jonathan R Edwards; Jean B Patel
Journal:  J Clin Microbiol       Date:  2009-12-23       Impact factor: 5.948

3.  Adaptation of Brucella melitensis Antimicrobial Susceptibility Testing to the ISO 20776 Standard and Validation of the Method.

Authors:  Alina Tscherne; Enrico Mantel; Talar Boskani; Sylwia Budniak; Mandy Elschner; Antonio Fasanella; Siri L Feruglio; Domenico Galante; Christian G Giske; Roland Grunow; Judit Henczko; Christin Hinz; Wojciech Iwaniak; Daniela Jacob; Agnieszka Kedrak-Jablonska; Veronica K Jensen; Tone B Johansen; Gunnar Kahlmeter; Viviana Manzulli; Erika Matuschek; Falk Melzer; Maria S Nuncio; Joseph Papaparaskevas; Ana Pelerito; Margrete Solheim; Susanne Thomann; Athanasios Tsakris; Tara Wahab; Marcin Weiner; Lothar Zoeller; Sabine Zange
Journal:  Microorganisms       Date:  2022-07-20
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.